{"id":12429,"date":"2025-10-09T17:15:00","date_gmt":"2025-10-09T15:15:00","guid":{"rendered":"https:\/\/irlab.se\/mfn_news\/irlab-utser-gustaf-albert-till-ny-chief-financial-officer\/"},"modified":"2025-10-09T17:15:00","modified_gmt":"2025-10-09T15:15:00","slug":"irlab-utser-gustaf-albert-till-ny-chief-financial-officer","status":"publish","type":"mfn_news","link":"https:\/\/irlab.se\/sv\/mfn_news\/irlab-utser-gustaf-albert-till-ny-chief-financial-officer\/","title":{"rendered":"IRLAB utser Gustaf Alb\u00e8rt till ny Chief Financial Officer"},"content":{"rendered":"
\n

G\u00f6teborg den 9 oktober 2025 \u2013 IRLAB Therapeutics AB (Nasdaq Stockholm: IRLAB A), ett bolag som uppt\u00e4cker och utvecklar nya behandlingar vid Parkinsons sjukdom, meddelar idag att bolaget har utsett Gustaf Alb\u00e8rt till ny Chief Financial Officer (CFO) och medlem av bolagets ledningsgrupp. Han har en gedigen bakgrund fr\u00e5n liknande seniora roller och tilltr\u00e4der positionen den 17 november.<\/strong><\/p>\n<\/div>\n

\n

Gustaf Alb\u00e8rt har omfattande erfarenhet fr\u00e5n ledande finansroller och har bland annat varit CFO och vice VD f\u00f6r Isofol Medical, Elanders Sverige och senast f\u00f6r biotechf\u00f6retaget Aqilion. Han har tidigare arbetat som auktoriserad revisor vid Deloitte och \u00e4r civilekonom samt har en magisterexamen i internationell redovisning och revision fr\u00e5n Handelsh\u00f6gskolan vid G\u00f6teborgs universitet.<\/p>\n

\u201dVi \u00e4r glada \u00f6ver att s\u00e5 snabbt kunna slutf\u00f6ra rekryteringen av en mycket erfaren och kompetent Chief Financial Officer till Irlab. Gustaf Alb\u00e8rt har en djup f\u00f6rst\u00e5else f\u00f6r de m\u00f6jligheter och utmaningar som pr\u00e4glar ett innovativt noterat life science-f\u00f6retag och jag ser fram emot hans bidrag till v\u00e5rt fortsatta v\u00e4rdeskapande\u201d, s\u00e4ger IRLAB:s vd Kristina Torfg\u00e5rd.<\/p>\n

Gustaf Alb\u00e8rt eftertr\u00e4der Roy Jonebrant som varit tillf\u00f6rordnad CFO sedan den 1 september 2025.<\/p>\n<\/div>\n

\n

F\u00f6r mer information<\/strong><\/p>\n

\n

Kristina Torfg\u00e5rd, VD
Tel: +46 730 60 70 99
E-post: kristina.torfgard@irlab.se<\/a><\/p>\n<\/div>\n

\n

Om IRLAB<\/strong><\/p>\n

\n

IRLAB uppt\u00e4cker och utvecklar en portf\u00f6lj av transformativa behandlingar f\u00f6r alla stadier av Parkinsons sjukdom. Bolaget har sitt ursprung i Nobelpristagaren Prof. Arvid Carlssons forskargrupp och uppt\u00e4ckten av ett samband mellan st\u00f6rningar i hj\u00e4rnans signalsubstanser och hj\u00e4rnans sjukdomar. Mesdopetam (IRL790), under utveckling f\u00f6r behandling av levodopa-inducerade dyskinesier, har slutf\u00f6rt Fas IIb och \u00e4r i f\u00f6rberedelse f\u00f6r Fas III. Pirepemat (IRL752), befinner sig f\u00f6r n\u00e4rvarande i Fas IIb, och utv\u00e4rderas f\u00f6r sin effekt p\u00e5 fallfrekvens vid Parkinson. IRL757, en substans som utvecklas f\u00f6r behandling av apati vid neurodegenerativa sjukdomar, befinner sig i Fas I. Dessutom utvecklar bolaget de tv\u00e5 prekliniska programmen IRL942 och IRL1117 mot Fas I-studier. IRLAB:s pipeline har genererats av bolagets egenutvecklade systembiologibaserade forskningsplattform Integrative Screening Process (ISP). IRLAB har sitt huvudkontor i Sverige och \u00e4r noterat p\u00e5 Nasdaq Stockholm (IRLAB A). F\u00f6r mer information, bes\u00f6k\u00a0www.irlab.se<\/a>.<\/p>\n<\/div>\n

\n

Bifogade filer<\/strong><\/p>\n

\n

IRLAB utser Gustaf Alb\u00e8rt till ny Chief Financial Officer<\/a><\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

G\u00f6teborg den 9 oktober 2025 \u2013 IRLAB Therapeutics AB (Nasdaq Stockholm: IRLAB A), ett bolag som uppt\u00e4cker och utvecklar nya behandlingar vid Parkinsons sjukdom, meddelar idag att bolaget har utsett Gustaf Alb\u00e8rt till ny Chief Financial Officer (CFO) och medlem av bolagets ledningsgrupp. Han har en gedigen bakgrund fr\u00e5n liknande seniora roller och tilltr\u00e4der positionen den 17 november.<\/p>\n","protected":false},"template":"","class_list":["post-12429","mfn_news","type-mfn_news","status-publish","hentry","mfn-news-tag-mfn-ci_sv","mfn-news-tag-mfn-type-ir_sv","mfn-news-tag-mfn-regulatory-listing_sv","mfn-news-tag-mfn_sv","mfn-news-tag-mfn-ci-staff_sv","mfn-news-tag-mfn-regulatory_sv","mfn-news-tag-mfn-lang-sv_sv"],"acf":[],"yoast_head":"\nIRLAB utser Gustaf Alb\u00e8rt till ny Chief Financial Officer - IRLAB<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/irlab.se\/sv\/mfn_news\/irlab-utser-gustaf-albert-till-ny-chief-financial-officer\/\" \/>\n<meta property=\"og:locale\" content=\"sv_SE\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"IRLAB utser Gustaf Alb\u00e8rt till ny Chief Financial Officer - IRLAB\" \/>\n<meta property=\"og:description\" content=\"G\u00f6teborg den 9 oktober 2025 \u2013 IRLAB Therapeutics AB (Nasdaq Stockholm: IRLAB A), ett bolag som uppt\u00e4cker och utvecklar nya behandlingar vid Parkinsons sjukdom, meddelar idag att bolaget har utsett Gustaf Alb\u00e8rt till ny Chief Financial Officer (CFO) och medlem av bolagets ledningsgrupp. Han har en gedigen bakgrund fr\u00e5n liknande seniora roller och tilltr\u00e4der positionen den 17 november.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/irlab.se\/sv\/mfn_news\/irlab-utser-gustaf-albert-till-ny-chief-financial-officer\/\" \/>\n<meta property=\"og:site_name\" content=\"IRLAB\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Ber\u00e4knad l\u00e4stid\" \/>\n\t<meta name=\"twitter:data1\" content=\"2 minuter\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/irlab.se\/sv\/mfn_news\/irlab-utser-gustaf-albert-till-ny-chief-financial-officer\/\",\"url\":\"https:\/\/irlab.se\/sv\/mfn_news\/irlab-utser-gustaf-albert-till-ny-chief-financial-officer\/\",\"name\":\"IRLAB utser Gustaf Alb\u00e8rt till ny Chief Financial Officer - IRLAB\",\"isPartOf\":{\"@id\":\"https:\/\/irlab.se\/#website\"},\"datePublished\":\"2025-10-09T15:15:00+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/irlab.se\/sv\/mfn_news\/irlab-utser-gustaf-albert-till-ny-chief-financial-officer\/#breadcrumb\"},\"inLanguage\":\"sv-SE\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/irlab.se\/sv\/mfn_news\/irlab-utser-gustaf-albert-till-ny-chief-financial-officer\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/irlab.se\/sv\/mfn_news\/irlab-utser-gustaf-albert-till-ny-chief-financial-officer\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/irlab.se\/sv\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"MFN News Items\",\"item\":\"https:\/\/irlab.se\/sv\/pressmeddelanden\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"IRLAB utser Gustaf Alb\u00e8rt till ny Chief Financial Officer\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/irlab.se\/#website\",\"url\":\"https:\/\/irlab.se\/\",\"name\":\"Irlab\",\"description\":\"Novel treatments for Parkinson's disease\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/irlab.se\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"sv-SE\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"IRLAB utser Gustaf Alb\u00e8rt till ny Chief Financial Officer - IRLAB","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/irlab.se\/sv\/mfn_news\/irlab-utser-gustaf-albert-till-ny-chief-financial-officer\/","og_locale":"sv_SE","og_type":"article","og_title":"IRLAB utser Gustaf Alb\u00e8rt till ny Chief Financial Officer - IRLAB","og_description":"G\u00f6teborg den 9 oktober 2025 \u2013 IRLAB Therapeutics AB (Nasdaq Stockholm: IRLAB A), ett bolag som uppt\u00e4cker och utvecklar nya behandlingar vid Parkinsons sjukdom, meddelar idag att bolaget har utsett Gustaf Alb\u00e8rt till ny Chief Financial Officer (CFO) och medlem av bolagets ledningsgrupp. Han har en gedigen bakgrund fr\u00e5n liknande seniora roller och tilltr\u00e4der positionen den 17 november.","og_url":"https:\/\/irlab.se\/sv\/mfn_news\/irlab-utser-gustaf-albert-till-ny-chief-financial-officer\/","og_site_name":"IRLAB","twitter_card":"summary_large_image","twitter_misc":{"Ber\u00e4knad l\u00e4stid":"2 minuter"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/irlab.se\/sv\/mfn_news\/irlab-utser-gustaf-albert-till-ny-chief-financial-officer\/","url":"https:\/\/irlab.se\/sv\/mfn_news\/irlab-utser-gustaf-albert-till-ny-chief-financial-officer\/","name":"IRLAB utser Gustaf Alb\u00e8rt till ny Chief Financial Officer - IRLAB","isPartOf":{"@id":"https:\/\/irlab.se\/#website"},"datePublished":"2025-10-09T15:15:00+00:00","breadcrumb":{"@id":"https:\/\/irlab.se\/sv\/mfn_news\/irlab-utser-gustaf-albert-till-ny-chief-financial-officer\/#breadcrumb"},"inLanguage":"sv-SE","potentialAction":[{"@type":"ReadAction","target":["https:\/\/irlab.se\/sv\/mfn_news\/irlab-utser-gustaf-albert-till-ny-chief-financial-officer\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/irlab.se\/sv\/mfn_news\/irlab-utser-gustaf-albert-till-ny-chief-financial-officer\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/irlab.se\/sv\/"},{"@type":"ListItem","position":2,"name":"MFN News Items","item":"https:\/\/irlab.se\/sv\/pressmeddelanden\/"},{"@type":"ListItem","position":3,"name":"IRLAB utser Gustaf Alb\u00e8rt till ny Chief Financial Officer"}]},{"@type":"WebSite","@id":"https:\/\/irlab.se\/#website","url":"https:\/\/irlab.se\/","name":"Irlab","description":"Novel treatments for Parkinson's disease","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/irlab.se\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"sv-SE"}]}},"_links":{"self":[{"href":"https:\/\/irlab.se\/sv\/wp-json\/wp\/v2\/mfn_news\/12429","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/irlab.se\/sv\/wp-json\/wp\/v2\/mfn_news"}],"about":[{"href":"https:\/\/irlab.se\/sv\/wp-json\/wp\/v2\/types\/mfn_news"}],"wp:attachment":[{"href":"https:\/\/irlab.se\/sv\/wp-json\/wp\/v2\/media?parent=12429"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}